Positive news with regards to a major trial can often propel a biotech or pharmaceutical stock to new highs and that is what happened with the Galectin Therapeutics (NASDAQ:GALT) stock on Friday. The company, which is based out of Georgia, saw its stock soar by as much as 25% yesterday after the company announced positive …
Continue reading “Galectin Therapeutics (NASDAQ:GALT) Stock Sees Big Rally: Time to Sell?”